EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy in Head and Neck Cancer—Where Are We Now and Where Are We Headed?

Rafał Becht iD, Kajetan Kiełbowski iD, Paulina Żukowska, Robert Kowalczyk, Sebastian Ochenduszko iD, Inmaculada Maestu Maiques iD, Katarzyna Radomska iD

International Journal of Molecular Sciences · 19.01.2026 · 27 (2) · 987

DOI: 10.3390/ijms27020987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.01.2026. Verfasst von Rafał Becht und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Chemotherapy and Cancer Immunotherapy, Pomeranian University of Medicine, 71-252 Szczecin, Poland. Hauptthemen laut MEDLINE: Immunotherapy, Head and Neck Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pomeranian Medical University in Szczecin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancer (HNC) encompasses tumors located within the oral cavity, sinonasal cavity, pharynx, and larynx. It is the sixth most common cancer worldwide. Current treatment methods in HNC patients involve radical surgery, radical radiotherapy, and concomitant chemoradiotherapy, along with adjuvant and induction therapies. Accumulating trials examine the role of immunotherapy in patients with HNC. The results of the CheckMate-141 and KEYNOTE-048 trials demonstrated the benefits of using immunotherapy in patients with metastatic or recurrent HNC. Subsequently, numerous other immunotherapy-based protocols have been evaluated. Then, KEYNOTE-689 successfully implemented immunotherapy in patients with locally advanced disease. This review aims to comprehensively present the landscape of immunotherapy opportunities in patients with HNC. It summarizes completed key clinical trials that led to the approval of immunotherapy in HNC and presents currently performed trials with highly expected results. Furthermore, it discusses methods to improve immunotherapy outcomes in the cohort of HNC patients, describes the current role of immunotherapy in HNC, and presents future perspectives of this type of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyHead and Neck NeoplasmsHumansImmune Checkpoint InhibitorsClinical Trials as Topic

Stichwörter der Autor:innen

biomarkershead and neck cancerimmune checkpoint inhibitorsimmunotherapysystemic treatment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Oncology, Chemotherapy and Cancer Immunotherapy, Pomeranian University of Medicine, 71-252 Szczecin, Poland.
  • Maxillo-Facial Surgery Clinic, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Department of Oncology, Dr. Peset University Hospital, Av.de Gaspar Aguilar 90, 46017 Valencia, Spain.
  • Department of Otolaryngology, Pomeranian University of Medicine, 71-252 Szczecin, Poland.

ORCID-Profile: Rafał Becht, Kajetan Kiełbowski, Sebastian Ochenduszko, Inmaculada Maestu Maiques, Katarzyna Radomska

Förderung

  • Pomeranian Medical University in Szczecin, Poland

Zitieren

APA

Becht, R., Kiełbowski, K., Żukowska, P., Kowalczyk, R., Ochenduszko, S., Maestu Maiques, I., & Radomska, K. (2026). Immunotherapy in Head and Neck Cancer—Where Are We Now and Where Are We Headed?. International Journal of Molecular Sciences, 27(2), 987. https://doi.org/10.3390/ijms27020987

Vancouver

Becht R, Kiełbowski K, Żukowska P, Kowalczyk R, Ochenduszko S, Maestu Maiques I, et al. Immunotherapy in Head and Neck Cancer—Where Are We Now and Where Are We Headed?. International Journal of Molecular Sciences. 2026;27(2):987. doi:10.3390/ijms27020987

BibTeX
@article{Becht2026,
  author = {Becht, Rafał and Kiełbowski, Kajetan and Żukowska, Paulina and Kowalczyk, Robert and Ochenduszko, Sebastian and Maestu Maiques, Inmaculada and Radomska, Katarzyna},
  title = {Immunotherapy in Head and Neck Cancer—Where Are We Now and Where Are We Headed?},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {987},
  doi = {10.3390/ijms27020987}
}
Kostenlos starten →